FDBusiness.com

Lonza celebrates 40 years as leading producer of vitamin B3

 Breaking News
  • Carlsberg Group Upgrades Full Year Operating Profit Outlook Carlsberg Group has delivered organic operating profit growth of 17.7% for the first half of 2019 with reported growth of 18.2% to DKr 5.17 billion (€693 million). Organic net revenue growth was 4.2% and on a reported basis net revenue rose by 6.5% to DKr32.99 (€4.42 billion). Operating margin improved by 160bp to 15.7%. Reported net [...]...
  • Diageo Forms New Rum Joint Venture Diageo and Corporación Cuba Ron, a leader in the production of premium Cuban rums, have created a joint venture – Ron Santiago. The joint venture will have exclusive global distribution rights to Santiago de Cuba, a premium Cuban heritage rum brand. Globally, premium and above rum segments are growing ahead of the category overall, with premiumisation [...]...
  • Stirring Times For US Yogurt – Innovation is Vital in a Changing Consumer Environment Over half of all U.S. consumers now buy yogurt as part of their typical grocery basket, according to a new report from Innova Market Insights, but their habits appear to be evolving. Convenience themes are becoming increasingly important, for example, with 17% of consumers naming this as a significant choice factor in 2018, which is [...]...
  • FrieslandCampina Significantly Expands its VLOG Production Due to the sharp increase in demand in Germany, FrieslandCampina is increasing the number of participating dairy farms that supply VLOG milk from 400 to more than 600. All VLOG milk produced by Dutch FrieslandCampina dairy farmers is used to make cheese for the German market. VLOG (Verband Lebensmittel Ohne Gentechnik) is a German association responsible [...]...
  • English Food Manufacturers Sign Up to Made Smarter Support A number of food manufacturing firms in the North West of England have signed up to a business-led programme which aims to use digital technology to boost growth and success. By implementing advances in data analytics, Artificial Intelligence (AI), Augmented Reality (AR), Industrial Internet of Things (IIoT), 3D-printing and robotics, firms can enhance their profitability [...]...

Lonza celebrates 40 years as leading producer of vitamin B3

November 10
11:15 2011

  • Since 1971, Lonza has supplied more than half the world’s demand for vitamin B3 in the

human and animal health nutrition industries.

 

  • Lonza’s new vitamin B3 manufacturing platform, located in Nansha, China, will provide

an additional 40 percent capacity – 15,000 metric tons per year.

 

  • Lonza has invested significantly to initiate a series of new research studies to further

understand the role supplemental niacin plays in both human and animal health.
Basel, Switzerland, 1 September 2011 – Lonza today announces the celebration of its 40th year of
Niacin production in Visp, Switzerland. As the world’s leading vitamin B3 producer for over four
decades, Lonza supplies greater than half the total vitamin B3 demand in the global feed and food
industries. To support future growth initiatives, a new vitamin B3 manufacturing facility is slated to
open at Lonza’s cutting edge life-sciences campus in Nansha, China, during the fourth quarter of
2012.
Lonza’s Niacin production first began in 1971 in Visp, Switzerland. To support ever-growing global
demand and quality requirements, two Niacinamide plants were subsequently constructed. In 1995,
Lonza broke ground in Guangzhou, China; while a second plant followed in 2003 in Nansha, China.
“Lonza’s multi-site concept, know-how and experience, as well as exceptional quality, service and
reliability have enabled us to become the leading partner to support the long-term growth for food
formulators and end-use product manufacturers of human and animal nutrition products,” said
Roman Quinter, Head of the Nutrition business unit. “As the global leader in vitamin B3 production,
Lonza continues to lead the nutrition industry in product quality and innovation, supported by
scientific research.”
The significance of vitamin B3 in humans was established in the 1930s when scientists discovered
that foods rich in this vitamin helped cure pellagra, a disease characterized by dermatitis, diarrhea
and dementia. If left untreated, it eventually leads to death. Once vitamin B3 supplementation was
considered essential, vitamin B3 deficiency in developed countries has been nearly eradicated.
This was mostly attributed to its addition in enriched foods such as flour. Additionally, vitamin B3 in
the form of niacin or niacinamide can be found in products such as functional foods and beverages,
dietary supplements and pharmaceuticals. Additionally, niacin is known for its beneficial impact on
the body’s lipid profile, specifically increasing the HDL, or “good cholesterol,” and lowering
triglycerides.
“Vitamin B3 can be found in all living cells, but it is not produced naturally in the body. It is therefore
considered essential and must be supplied to the body through diet or direct supplementation,” said Kevin Owen, Ph.D., NAFTA head of technical marketing and scientific affairs at Lonza. “Therefore, niacin is a critical component of the global food and feed industries.”
In the feed industry, nutritionists agree that niacin supplementation is required in every swine and
poultry diet to meet the body’s basal requirement. In 2010, it was estimated that over 18 billion
chickens and over 950 million pigs received vitamin B3 supplements in their feed, with most of the
Niacin originating from Lonza. As the global leader in the vitamin B3 market, Lonza has initiated a
series of new research studies to further define the role that supplemental niacin plays in improving
animal health, optimizing productivity and increasing economic return for the farmer.
Vitamin B3 has a long history within the human and animal nutrition industries, and Lonza continues
to be the global leader in vitamin B3 supply, information, and technology.
About Lonza
Lonza is one of the world’s leading suppliers to the pharmaceutical, healthcare and life science
industries. Products and services span its customers’ needs from research to final product
manufacture. It is the global leader in the production and support of active pharmaceutical
ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key
growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in
large and small molecules, peptides, amino acids and niche bioproducts which play an important
role in the development of novel medicines and healthcare products. In addition, Lonza is a leader
in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the
company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene,
preservation, agro and personal care markets.

About Author

colin

colin

Related Articles

Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 11, 2019Packaging Innovations & Luxury Packaging London 2019
  • October 1, 2019PPMA Total Show
  • October 17, 2019Future Food-Tech
  • November 18, 2019Plastics Caps and Closures Conference 2019
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements